OTCBB Nanotechnology Stock
, however, was discontinued and substantially all assets were sold in November of 1996. From that time until February 1998, the Company was generally inactive and reported no significant operating revenues.
more
Ener1 Inc. produces electrical equipment such as Lithium-ion batteries, fuel cells, and nanotechnology-related manufacturing processes and materials.
more
We are a global biotechnology company that develops, manufactures and markets nutraceuticals, or functional foods that offer health promoting advantages beyond that of nutrition. Our primary products are our plant sterol products, including our CZTM Series of food additives and our CholZeroTM branded beverages and capsules.
more
We
are a development stage biotechnology company that has licensed patents for a
series of compounds for the treatment of viral diseases including compounds for
the treatment of VZV, the causative agent for shingles and chickenpox and CMV,
a member of the herpes virus group which includes the viruses that cause
chicken pox, mononucleosis, herpes labialis (cold sores) and genitalis (genital ...
more
Sono-Tek Corporation (the "Company", "Sono-Tek", "We" or "Our") was incorporated in New York on March 21, 1975 for the purpose of engaging in the development, manufacture and sale of ultrasonic liquid atomizing nozzles. Ultrasonic nozzle systems atomize low to medium viscosity liquids by converting electrical energy into mechanical motion in the form of high frequency ultrasonic vibrations ...
more
Enable IPC Corporation (“Enable”, “we” or “us”) is a Delaware corporation established to develop and commercialize rechargeable batteries for use in low power applications. Our initial product will be a thin film lithium battery developed from licensed technology. A patent application covering this technology was assigned to us in March 2005 by ...
more
GENERAL. InMedica Development Corporation ("InMedica" or the "Company") was incorporated as a Utah corporation on June 16, 1983. During the last three fiscal years, InMedica's primary activity has been the operation of the business of MicroCor, Inc. ("MicroCor"), a 57% owned subsidiary, and the negotiation and finalization of a Joint Development Agreement (the "Agreement") with ...
more
Kyto Biopharma, Inc. was formed to acquire a patent portfolio and the rights to early-stage compounds which have potential use as therapeutic agents for the treatment of cancer and diseases of the immune system.
more
NOTE REGARDING FORWARD LOOKING STATEMENTS: THIS ANNUAL REPORT ON FORM 10-K CONTAINS "FORWARD-LOOKING STATEMENTS" WITHIN THE MEANING OF SECTION 27A OF THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (THE "EXCHANGE ACT"). THESE STATEMENTS MAY BE IDENTIFIED BY THE USE OF FORWARD-LOOKING WORDS OR PHRASES SUCH AS ...
more
Precision
Optics Corporation, Inc. (the “Company”) was incorporated in Massachusetts in
1982 and has been publicly owned since November 1990. References to the Company
contained herein include its two wholly-owned subsidiaries, except where the
context otherwise requires.
more
" in this Annual Report on Form 10-KSB are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by forward-looking statements.
more
